Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen

Bone Marrow Transplantation

Volumn 47, Issue 10, 2012, Pages 1287-1293

  Sanz, J ^a   Boluda, J C H ^b   Martin C ^c   Gonzalez M ^d   Ferra C ^e   Serrano, D ^f   De Heredia, C D ^g   Barrenetxea, C ^h   Martinez, A M ⁱ   Solano, C ^b   Sanz, M A ^a   Sanz, G F ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Myeloablative conditioning regimen; Transplantation; Umbilical cord blood

Indexed keywords

BUSULFAN; FLUDARABINE; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; ENGRAFTMENT; FEMALE; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOABLATIVE CONDITIONING; MYELOID ENGRAFTMENT; NEUTROPHIL; NEUTROPHIL RECOVERY; NONRELAPSE MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENCE RISK; SCHOOL CHILD; SPAIN; UNRELATED DONORS;

ADOLESCENT; ADULT; ANTILYMPHOCYTE SERUM; BUSULFAN; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; GRAFT SURVIVAL; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; NEOPLASM STAGING; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; THIOTEPA; TRANSPLANTATION CONDITIONING; UNRELATED DONORS; VIDARABINE;

EID: 84867397448     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.13     Document Type: Article

References (28)

1. Sanz MA. Cord-blood transplantation in patients with leukemia - a real alternative for adults. N Engl J Med 2004; 351: 2328-2330.
2. Smith AR, Wagner JE. Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood. Br J Haematol 2009; 147: 246-261.
3. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS et al. Transplantation of two partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105: 1343-1347.
4. Fernandez MN, Regidor C, Cabrera R, García-Marco JA, Forés R, Sanjuán I et al. Unrelated umbilical cord blood transplant in adults: early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA haploidentical donor. Exp Hematol 2003; 31: 535-544.
5. Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002; 8: 368-376.
6. Frassoni N, Gualandi F, Modesta M, Raiola AM, Ibatici A, Piaggio G et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol 2008; 9: 831-839.
7. Sanz GF, Saavedra S, Planelles D, Senent L, Cervera J, Barragán E et al. Standardized unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001; 98: 2332-2338.
8. De Lima M, Couriel D, Thall PF. Once-daily busulfan and fludarabine: clinical and pharmacokinetics results of a myeloablative reduced toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. Blood 2004; 104: 857-864.
9. Montesinos P, Sanz J, Cantero S, Lorenzo I, Martin G, Saavedra S et al. Incidence outcome and risk factors of cytomegalovirus infection and disease after umbilical cord-blood transplantation in adult patients. Biol Blood Marrow Transplant 2009; 15: 730-740.
10. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
11. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
12. Shulman HM, Sullivan KM, Weiden PI, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
13. Gooley TA, Leisenring W, Crowley JA, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 665-706.
14. Fine JP, Gray RJ. A proportional hazards model for subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
16. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
17. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972; 34: 187-220.
18. Dixon WJ. BMDP Statistical Software. University of California Press: Berkeley, CA, 1990.
19. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study. Lancet 2007; 369: 1947-1954.
20. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276-2285.
21. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265-2275.
22. Horwitz ME, Morris A, Gasparetto C, Sullivan K, Long G, Chute J et al. Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients. Biol Blood Marrow Transplant 2008; 14: 591-594.
23. Papadopoulos EB, Carabasi MH, Castro-Malaspina H, Childs BH, Mackinnon S, Boulad F et al. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. Blood 1998; 91: 1083-1090.
24. Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched haplotype. N Engl J Med 1998; 339: 1186-1193.
25. MoscardóF, Sanz J, Senent L, Cantero S, de la Rubia J, Montesinos P et al. Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies. Haematologica 2009; 94: 827-832.
26. Ooi J, Takahashi S, Tomonari A, Tsukada N, Konuma T, Kato S et al. Unrelated cord blood transplantation after myeloablative conditioning in adults with acute myelogenous leukemia. Biol Blood Marrow Transplant 2008; 14: 1341-1347.
27. Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Blazar BR et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplant outcomes in 110 adults with hematological disease. Blood 2007; 110: 3064-3070.
28. MacMillan ML, Weisdorf DJ, Brunstein CG, Cao Q, DeFor TE, Verneris MR et al. Acute graft-versus-host disease after unrelated donor cord blood transplantation: analysis of risk factors. Blood 2009; 113: 2410-2415.